Stage III Non-Small Cell Lung Cancer AJCC v7
6 clinical trials · Condition
◉ Watch Stage III Non-Small Cell Lung Cancer AJCC v7
| Record | Firm | Date |
|---|---|---|
| Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer (NCT03455556) | Mayo Clinic | 2018-08-10 |
| Collection of Blood Samples in Patients With Non-small Cell Lung Cancer (NCT03492801) | University of Southern California | 2017-12-11 |
| Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma (NCT03229278) | Rutgers, The State University of New Jersey | 2017-10-03 |
| Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma (NCT02408016) | Fred Hutchinson Cancer Center | 2015-05-22 |
| Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer (NCT01993810) | Radiation Therapy Oncology Group | 2014-01-03 |
| Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer (NCT01822496) | National Cancer Institute (NCI) | 2013-11-04 |
Track Stage III Non-Small Cell Lung Cancer AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.